wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26775390-15D4ABCD-4983-47B6-BA2C-141D8E02A974
Q26775390-15D4ABCD-4983-47B6-BA2C-141D8E02A974
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775390-15D4ABCD-4983-47B6-BA2C-141D8E02A974
Novel therapies in small cell lung cancer
P2860
Q26775390-15D4ABCD-4983-47B6-BA2C-141D8E02A974
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775390-15D4ABCD-4983-47B6-BA2C-141D8E02A974
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
286405b685b32c5faae80307dc1a881307295663
P2860
A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.